Click for best price
Bioengineered Protein Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 86200 million
|
Forecast Market size by 2029 |
US$ 112310 million
|
| Growth Rate |
CAGR of 3.9% |
Number of Pages |
70 Pages |
This report aims to provide a comprehensive presentation of the global market for Bioengineered Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioengineered Protein Drugs. This report contains market size and forecasts of Bioengineered Protein Drugs in global, including the following market information:
Global Bioengineered Protein Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bioengineered Protein Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Bioengineered Protein Drugs companies in 2022 (%)
The global Bioengineered Protein Drugs market was valued at US$ 86200 million in 2022 and is projected to reach US$ 112310 million by 2029, at a CAGR of 3.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Bioengineered proteins are designed as the fundamental participants in all biological processes, represent as powerful therapeutic agents and include a broad range of products such as growth factors, hormones, vaccines, monoclonal antibodies, cytokines and few others. These special drugs are gaining attention across pharmaceutical industries due to their specificity, safety, bioreactivity and success rate in treating life-threatening diseases and injuries.
We surveyed the Bioengineered Protein Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioengineered Protein Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bioengineered Protein Drugs Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Therapeutic Proteins
Vaccines
Global Bioengineered Protein Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bioengineered Protein Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Diabetes
Autoimmune Disorder
Infectious Disease
Neurodegenerative
Others
Global Bioengineered Protein Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bioengineered Protein Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bioengineered Protein Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bioengineered Protein Drugs revenues share in global market, 2022 (%)
Key companies Bioengineered Protein Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Bioengineered Protein Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr.Reddy?s
Eli Lilly
Merck
Reliance Life Sciences
Panacea Biotech
Novartis
Fresenius
Sanofi
ProBioGen
GlaxoSmithKline
Roche
Amoytop Biotech
Shanghai United Cell Biotechnology
Hualan Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bioengineered Protein Drugs, market overview.
Chapter 2: Global Bioengineered Protein Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Bioengineered Protein Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bioengineered Protein Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bioengineered Protein Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Bioengineered Protein Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 86200 million
|
| Forecast Market size by 2029 |
US$ 112310 million
|
| Growth Rate |
CAGR of 3.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bioengineered Protein Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bioengineered Protein Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bioengineered Protein Drugs Overall Market Size
2.1 Global Bioengineered Protein Drugs Market Size: 2022 VS 2029
2.2 Global Bioengineered Protein Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bioengineered Protein Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Bioengineered Protein Drugs Players in Global Market
3.2 Top Global Bioengineered Protein Drugs Companies Ranked by Revenue
3.3 Global Bioengineered Protein Drugs Revenue by Companies
3.4 Global Bioengineered Protein Drugs Sales by Companies
3.5 Global Bioengineered Protein Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bioengineered Protein Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bioengineered Protein Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bioengineered Protein Drugs Players in Global Market
3.8.1 List of Global Tier 1 Bioengineered Protein Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Bioengineered Protein Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bioengineered Protein Drugs Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Proteins
4.1.4 Vaccines
4.2 By Type - Global Bioengineered Protein Drugs Revenue & Forecasts
4.2.1 By Type - Global Bioengineered Protein Drugs Revenue, 2018-2023
4.2.2 By Type - Global Bioengineered Protein Drugs Revenue, 2024-2029
4.2.3 By Type - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Bioengineered Protein Drugs Sales & Forecasts
4.3.1 By Type - Global Bioengineered Protein Drugs Sales, 2018-2023
4.3.2 By Type - Global Bioengineered Protein Drugs Sales, 2024-2029
4.3.3 By Type - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Bioengineered Protein Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bioengineered Protein Drugs Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Autoimmune Disorder
5.1.5 Infectious Disease
5.1.6 Neurodegenerative
5.1.7 Others
5.2 By Application - Global Bioengineered Protein Drugs Revenue & Forecasts
5.2.1 By Application - Global Bioengineered Protein Drugs Revenue, 2018-2023
5.2.2 By Application - Global Bioengineered Protein Drugs Revenue, 2024-2029
5.2.3 By Application - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Bioengineered Protein Drugs Sales & Forecasts
5.3.1 By Application - Global Bioengineered Protein Drugs Sales, 2018-2023
5.3.2 By Application - Global Bioengineered Protein Drugs Sales, 2024-2029
5.3.3 By Application - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Bioengineered Protein Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Bioengineered Protein Drugs Market Size, 2022 & 2029
6.2 By Region - Global Bioengineered Protein Drugs Revenue & Forecasts
6.2.1 By Region - Global Bioengineered Protein Drugs Revenue, 2018-2023
6.2.2 By Region - Global Bioengineered Protein Drugs Revenue, 2024-2029
6.2.3 By Region - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Bioengineered Protein Drugs Sales & Forecasts
6.3.1 By Region - Global Bioengineered Protein Drugs Sales, 2018-2023
6.3.2 By Region - Global Bioengineered Protein Drugs Sales, 2024-2029
6.3.3 By Region - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Bioengineered Protein Drugs Revenue, 2018-2029
6.4.2 By Country - North America Bioengineered Protein Drugs Sales, 2018-2029
6.4.3 US Bioengineered Protein Drugs Market Size, 2018-2029
6.4.4 Canada Bioengineered Protein Drugs Market Size, 2018-2029
6.4.5 Mexico Bioengineered Protein Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Bioengineered Protein Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Bioengineered Protein Drugs Sales, 2018-2029
6.5.3 Germany Bioengineered Protein Drugs Market Size, 2018-2029
6.5.4 France Bioengineered Protein Drugs Market Size, 2018-2029
6.5.5 U.K. Bioengineered Protein Drugs Market Size, 2018-2029
6.5.6 Italy Bioengineered Protein Drugs Market Size, 2018-2029
6.5.7 Russia Bioengineered Protein Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Bioengineered Protein Drugs Market Size, 2018-2029
6.5.9 Benelux Bioengineered Protein Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Bioengineered Protein Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Bioengineered Protein Drugs Sales, 2018-2029
6.6.3 China Bioengineered Protein Drugs Market Size, 2018-2029
6.6.4 Japan Bioengineered Protein Drugs Market Size, 2018-2029
6.6.5 South Korea Bioengineered Protein Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Bioengineered Protein Drugs Market Size, 2018-2029
6.6.7 India Bioengineered Protein Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Bioengineered Protein Drugs Revenue, 2018-2029
6.7.2 By Country - South America Bioengineered Protein Drugs Sales, 2018-2029
6.7.3 Brazil Bioengineered Protein Drugs Market Size, 2018-2029
6.7.4 Argentina Bioengineered Protein Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Bioengineered Protein Drugs Sales, 2018-2029
6.8.3 Turkey Bioengineered Protein Drugs Market Size, 2018-2029
6.8.4 Israel Bioengineered Protein Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Bioengineered Protein Drugs Market Size, 2018-2029
6.8.6 UAE Bioengineered Protein Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Dr.Reddy?s
7.1.1 Dr.Reddy?s Company Summary
7.1.2 Dr.Reddy?s Business Overview
7.1.3 Dr.Reddy?s Bioengineered Protein Drugs Major Product Offerings
7.1.4 Dr.Reddy?s Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Dr.Reddy?s Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Bioengineered Protein Drugs Major Product Offerings
7.2.4 Eli Lilly Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Bioengineered Protein Drugs Major Product Offerings
7.3.4 Merck Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Reliance Life Sciences
7.4.1 Reliance Life Sciences Company Summary
7.4.2 Reliance Life Sciences Business Overview
7.4.3 Reliance Life Sciences Bioengineered Protein Drugs Major Product Offerings
7.4.4 Reliance Life Sciences Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Reliance Life Sciences Key News & Latest Developments
7.5 Panacea Biotech
7.5.1 Panacea Biotech Company Summary
7.5.2 Panacea Biotech Business Overview
7.5.3 Panacea Biotech Bioengineered Protein Drugs Major Product Offerings
7.5.4 Panacea Biotech Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Panacea Biotech Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Bioengineered Protein Drugs Major Product Offerings
7.6.4 Novartis Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Fresenius
7.7.1 Fresenius Company Summary
7.7.2 Fresenius Business Overview
7.7.3 Fresenius Bioengineered Protein Drugs Major Product Offerings
7.7.4 Fresenius Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Fresenius Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Bioengineered Protein Drugs Major Product Offerings
7.8.4 Sanofi Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 ProBioGen
7.9.1 ProBioGen Company Summary
7.9.2 ProBioGen Business Overview
7.9.3 ProBioGen Bioengineered Protein Drugs Major Product Offerings
7.9.4 ProBioGen Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.9.5 ProBioGen Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Bioengineered Protein Drugs Major Product Offerings
7.10.4 GlaxoSmithKline Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
7.11 Roche
7.11.1 Roche Company Summary
7.11.2 Roche Bioengineered Protein Drugs Business Overview
7.11.3 Roche Bioengineered Protein Drugs Major Product Offerings
7.11.4 Roche Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Roche Key News & Latest Developments
7.12 Amoytop Biotech
7.12.1 Amoytop Biotech Company Summary
7.12.2 Amoytop Biotech Bioengineered Protein Drugs Business Overview
7.12.3 Amoytop Biotech Bioengineered Protein Drugs Major Product Offerings
7.12.4 Amoytop Biotech Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Amoytop Biotech Key News & Latest Developments
7.13 Shanghai United Cell Biotechnology
7.13.1 Shanghai United Cell Biotechnology Company Summary
7.13.2 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Business Overview
7.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Major Product Offerings
7.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Shanghai United Cell Biotechnology Key News & Latest Developments
7.14 Hualan Bio
7.14.1 Hualan Bio Company Summary
7.14.2 Hualan Bio Business Overview
7.14.3 Hualan Bio Bioengineered Protein Drugs Major Product Offerings
7.14.4 Hualan Bio Bioengineered Protein Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Hualan Bio Key News & Latest Developments
8 Global Bioengineered Protein Drugs Production Capacity, Analysis
8.1 Global Bioengineered Protein Drugs Production Capacity, 2018-2029
8.2 Bioengineered Protein Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Bioengineered Protein Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bioengineered Protein Drugs Supply Chain Analysis
10.1 Bioengineered Protein Drugs Industry Value Chain
10.2 Bioengineered Protein Drugs Upstream Market
10.3 Bioengineered Protein Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bioengineered Protein Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Bioengineered Protein Drugs in Global Market
Table 2. Top Bioengineered Protein Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Bioengineered Protein Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Bioengineered Protein Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Bioengineered Protein Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Bioengineered Protein Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Bioengineered Protein Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Bioengineered Protein Drugs Product Type
Table 9. List of Global Tier 1 Bioengineered Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioengineered Protein Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Bioengineered Protein Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Bioengineered Protein Drugs Sales (Units), 2024-2029
Table 16. By Application ? Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Bioengineered Protein Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Bioengineered Protein Drugs Sales (Units), 2024-2029
Table 21. By Region ? Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Bioengineered Protein Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Bioengineered Protein Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Bioengineered Protein Drugs Sales (Units), 2024-2029
Table 26. By Country - North America Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Bioengineered Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Bioengineered Protein Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Bioengineered Protein Drugs Sales, (Units), 2024-2029
Table 30. By Country - Europe Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Bioengineered Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Bioengineered Protein Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Bioengineered Protein Drugs Sales, (Units), 2024-2029
Table 34. By Region - Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Bioengineered Protein Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Bioengineered Protein Drugs Sales, (Units), 2024-2029
Table 38. By Country - South America Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Bioengineered Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Bioengineered Protein Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Bioengineered Protein Drugs Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Bioengineered Protein Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Bioengineered Protein Drugs Sales, (Units), 2024-2029
Table 46. Dr.Reddy?s Company Summary
Table 47. Dr.Reddy?s Bioengineered Protein Drugs Product Offerings
Table 48. Dr.Reddy?s Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Dr.Reddy?s Key News & Latest Developments
Table 50. Eli Lilly Company Summary
Table 51. Eli Lilly Bioengineered Protein Drugs Product Offerings
Table 52. Eli Lilly Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Eli Lilly Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Bioengineered Protein Drugs Product Offerings
Table 56. Merck Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Reliance Life Sciences Company Summary
Table 59. Reliance Life Sciences Bioengineered Protein Drugs Product Offerings
Table 60. Reliance Life Sciences Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Reliance Life Sciences Key News & Latest Developments
Table 62. Panacea Biotech Company Summary
Table 63. Panacea Biotech Bioengineered Protein Drugs Product Offerings
Table 64. Panacea Biotech Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Panacea Biotech Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Bioengineered Protein Drugs Product Offerings
Table 68. Novartis Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Fresenius Company Summary
Table 71. Fresenius Bioengineered Protein Drugs Product Offerings
Table 72. Fresenius Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Fresenius Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Bioengineered Protein Drugs Product Offerings
Table 76. Sanofi Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. ProBioGen Company Summary
Table 79. ProBioGen Bioengineered Protein Drugs Product Offerings
Table 80. ProBioGen Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. ProBioGen Key News & Latest Developments
Table 82. GlaxoSmithKline Company Summary
Table 83. GlaxoSmithKline Bioengineered Protein Drugs Product Offerings
Table 84. GlaxoSmithKline Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. GlaxoSmithKline Key News & Latest Developments
Table 86. Roche Company Summary
Table 87. Roche Bioengineered Protein Drugs Product Offerings
Table 88. Roche Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Roche Key News & Latest Developments
Table 90. Amoytop Biotech Company Summary
Table 91. Amoytop Biotech Bioengineered Protein Drugs Product Offerings
Table 92. Amoytop Biotech Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Amoytop Biotech Key News & Latest Developments
Table 94. Shanghai United Cell Biotechnology Company Summary
Table 95. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Offerings
Table 96. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Shanghai United Cell Biotechnology Key News & Latest Developments
Table 98. Hualan Bio Company Summary
Table 99. Hualan Bio Bioengineered Protein Drugs Product Offerings
Table 100. Hualan Bio Bioengineered Protein Drugs Sales (Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Hualan Bio Key News & Latest Developments
Table 102. Bioengineered Protein Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 103. Global Bioengineered Protein Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Bioengineered Protein Drugs Production by Region, 2018-2023 (Units)
Table 105. Global Bioengineered Protein Drugs Production by Region, 2024-2029 (Units)
Table 106. Bioengineered Protein Drugs Market Opportunities & Trends in Global Market
Table 107. Bioengineered Protein Drugs Market Drivers in Global Market
Table 108. Bioengineered Protein Drugs Market Restraints in Global Market
Table 109. Bioengineered Protein Drugs Raw Materials
Table 110. Bioengineered Protein Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Bioengineered Protein Drugs Downstream
Table 112. Bioengineered Protein Drugs Downstream Clients in Global Market
Table 113. Bioengineered Protein Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bioengineered Protein Drugs Segment by Type in 2022
Figure 2. Bioengineered Protein Drugs Segment by Application in 2022
Figure 3. Global Bioengineered Protein Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bioengineered Protein Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bioengineered Protein Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Bioengineered Protein Drugs Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Bioengineered Protein Drugs Revenue in 2022
Figure 9. By Type - Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Bioengineered Protein Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Bioengineered Protein Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Bioengineered Protein Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Bioengineered Protein Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 23. US Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 28. Germany Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 37. China Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Bioengineered Protein Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Bioengineered Protein Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Bioengineered Protein Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Bioengineered Protein Drugs Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Bioengineered Protein Drugs by Region, 2022 VS 2029
Figure 54. Bioengineered Protein Drugs Industry Value Chain
Figure 55. Marketing Channels
